COST-EFFECTIVENESS OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPIES FOR BLOOD CANCERS: A SYSTEMATIC REVIEW

被引：0
|
作者：
Patel, N. [1 ]
Farid, S. [1 ]
Gomes, M. [1 ]
机构：
[1] UCL, London, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE320
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [1] Infectious complications of chimeric antigen receptor (CAR) T-cell therapies
    Gea-Banacloche, Juan C.
    SEMINARS IN HEMATOLOGY, 2023, 60 (01) : 52 - 58
  • [2] LITERATURE REVIEW ON TOTAL MEDICAL COSTS AND COST COMPONENTS OF CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPIES
    Ma, Q.
    Kuzan, D.
    Zhang, J.
    VALUE IN HEALTH, 2019, 22 : S422 - S422
  • [3] Chimeric Antigen Receptor T-Cell Immunotherapy Tackles Blood Cancers
    Brower, Vicki
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (04):
  • [4] FDG-PET in Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy Toxicity: A Systematic Review
    Al-Ibraheem, Akram
    Abdlkadir, Ahmed Saad
    Lopci, Egesta
    Allouzi, Sudqi
    Paez, Diana
    Alkuwari, Maryam
    Makoseh, Mohammad
    Novruzov, Fuad
    Usmani, Sharjeel
    Al-Rabi, Kamal
    Mansour, Asem
    CANCERS, 2024, 16 (09)
  • [5] COST OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY RELATED TOXICITIES
    Patel, N.
    Farid, S.
    Gomes, M.
    VALUE IN HEALTH, 2023, 26 (12) : S196 - S196
  • [6] Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
    Ajeet Gajra
    Abigail Zalenski
    Aishwarya Sannareddy
    Yolaine Jeune-Smith
    Kandice Kapinos
    Ankit Kansagra
    Pharmaceutical Medicine, 2022, 36 : 163 - 171
  • [7] Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
    Gajra, Ajeet
    Zalenski, Abigail
    Sannareddy, Aishwarya
    Jeune-Smith, Yolaine
    Kapinos, Kandice
    Kansagra, Ankit
    PHARMACEUTICAL MEDICINE, 2022, 36 (03) : 163 - 171
  • [8] Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Pagel, John M.
    West, Howard
    JAMA ONCOLOGY, 2017, 3 (11) : 1595 - 1595
  • [9] HEALTH TECHNOLOGY ASSESSMENT FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPIES FOR CANCER
    Hollier-Hann, G.
    Brown, A.
    Ralston, S.
    Curry, A.
    Cork, D.
    VALUE IN HEALTH, 2018, 21 : S65 - S65
  • [10] Chimeric antigen receptor T-cell therapies for lymphoma
    Brudno, Jennifer N.
    Kochenderfer, James N.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (01) : 31 - 46
12345